Sfoglia per Rivista BIOCHEMICAL PHARMACOLOGY
Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+breast cancer cells
2023-01-01 Bellese, G; Tagliatti, E; Gagliani, Mc; Santamaria, S; Arnaldi, P; Falletta, P; Rusmini, P; Matteoli, M; Castagnola, P; Cortese, K
Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+breast cancer cells
2023-01-01 Bellese, G; Tagliatti, E; Gagliani, Mc; Santamaria, S; Arnaldi, P; Falletta, P; Rusmini, P; Matteoli, M; Castagnola, P; Cortese, K
The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo
2010-01-01 Brunelli, D; Tavecchio, M; Falcioni, C; Frapolli, R; Erba, E; Iori, R; Rollin, P; Barillari, J; Manzotti, C; Morazzoni, P; D'Incalci, M
The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism
2007-01-01 Di Francesco, Am; Meco, D; Torella, Ar; Barone, G; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan
2005-01-01 Di Francesco, Am; Riccardi, As; Barone, G; Rutella, S; Meco, D; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R
Trabectedin suppresses escape from therapy-induced senescence in tumor cells by interfering with glutamine metabolism
2022-01-01 Pacifico, Francesco; Mellone, Stefano; D'Incalci, Maurizio; Stornaiuolo, Mariano; Leonardi, Antonio; Crescenzi, Elvira
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+breast cancer cells | 1-gen-2023 | Bellese, G; Tagliatti, E; Gagliani, Mc; Santamaria, S; Arnaldi, P; Falletta, P; Rusmini, P; Matteoli, M; Castagnola, P; Cortese, K | |
| Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+breast cancer cells | 1-gen-2023 | Bellese, G; Tagliatti, E; Gagliani, Mc; Santamaria, S; Arnaldi, P; Falletta, P; Rusmini, P; Matteoli, M; Castagnola, P; Cortese, K | |
| The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo | 1-gen-2010 | Brunelli, D; Tavecchio, M; Falcioni, C; Frapolli, R; Erba, E; Iori, R; Rollin, P; Barillari, J; Manzotti, C; Morazzoni, P; D'Incalci, M | |
| The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism | 1-gen-2007 | Di Francesco, Am; Meco, D; Torella, Ar; Barone, G; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R | |
| The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan | 1-gen-2005 | Di Francesco, Am; Riccardi, As; Barone, G; Rutella, S; Meco, D; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R | |
| Trabectedin suppresses escape from therapy-induced senescence in tumor cells by interfering with glutamine metabolism | 1-gen-2022 | Pacifico, Francesco; Mellone, Stefano; D'Incalci, Maurizio; Stornaiuolo, Mariano; Leonardi, Antonio; Crescenzi, Elvira |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile